| Filed On | Filing |
|---|---|
| 29 Jun 2026 | Form 3: Costa Andrew, Director |
| 24 Jun 2026 | Form 3: Burke April Lynn, Director |
| 23 Jun 2026 | Form 3: Bastiani-Posner Ana Lucia, Director |
| 27 May 2026 |
Form 3: Wright Michael G., 10% owner
Holds 750,000 shares of Common Stock |
| 11 May 2026 |
Form 3: OnePointTwo Capital Ventures Ii Llc, 10% owner
Holds 1,484,240 shares of Common Stock |
| 11 May 2026 |
Form 3: OnePointTwo Capital Ventures Llc, 10% owner
Holds 625,000 shares of Common Stock |
| 11 May 2026 |
Form 3: Purcell Lynn Sebastian, Director
Holds 625,000 shares of Common Stock |
| 11 May 2026 |
Form 3: Bogart David Robert, Director
Holds 1,062,500 shares of Common Stock |
| 11 May 2026 |
Form 3: Farberg Aaron Solomon, Director
Holds 10,869 shares of Common Stock |
| 11 May 2026 |
Form 3: Pilcher Brian Keith, Chief Medical Officer
Holds 87,861 shares of Common Stock |
| 11 May 2026 |
Form 3: Lorenc Zbigniew Paul, Director
Holds 422,148 shares of Common Stock |
| 11 May 2026 |
Form 3: Chavez-Munoz Claudia Itze, Chief Science Officer
Holds 444,111 shares of Common Stock |
| 11 May 2026 |
Form 3: Sharpe Jeffrey Nathan, Director
Holds 500,000 shares of Common Stock |
| 11 May 2026 |
Form 3: Inouye Stephen Douglas, CFO, Secretary, and Treasurer
Holds 57,525 shares of Common Stock |
| 11 May 2026 |
Form 3: Harrison Miles David, Director
Holds 87,861 shares of Common Stock |
Loading...